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Introduction
It is estimated that 50% of people born after 1960 in the UK will develop some form of
cancer in their lifetime 1. Cancer treatments include surgery, radiotherapy and
chemotherapy. Each of these methods carries a risk of damaging healthy tissues
surrounding the tumour.
Nanotechnology offers novel tools for cancer diagnosis, early detection and treatments 2.
Gold nanoparticles show great promise in targeted cancer therapy due to their unique
physicochemical properties. They offer the advantage of interaction with biomolecules
both at the cell surface level and inside the cell 3,4 . This interaction is highly dependent on
their ligand composition.
Midatech’s technology is based on carbohydrate-coated gold nanoparticles (GNPs). The
particles used in this project consist of a gold core with an average diameter of ca. 2nm to
which an organic layer of a thiolated α-Galactose derivative and thiol PEG amine are
attached via gold-sulphur bonds (Figure 1). The highly water-soluble carbohydrate layer
provides colloidal stability in aqueous solutions, while the thiol PEG amine creates positive
charges which enable the particle to interact with biomolecules.
→  The key advantages are:
1.  Synthesis of GNPs
- GNPs were synthesized by the reduction of HAuCl4 with NaBH4 in the presence of
disulfide-containing ligands (Figure 2).
2.  Clonogenic Assays
- Isolated human skin cancer (HSC-3) and normal (HaCaT) cells (300 cells/well) were
exposed to different GNP concentrations for 3h and left to grow for 6 days to form
colonies.
- At the end of day 6, cells were briefly rinsed with water, stained and fixed with 2%
methylene blue in 50% ethanol.
- The staining/fixation solution was removed and plates were washed with distilled water
and dried. Colonies with >50 cells were counted.
3. Silver Staining
- After acute exposure of cells to GNPs for 3h, cells were washed with PBS and fixed in
4% PFA for 15 min. The cell membrane was permeabilized with 0.05% Tx-100 in PBS.
- The silver staining developer and enhancer solutions were mixed at 50:50 ratio and
applied to cells for 5-10 min in the dark. Cells were then washed 2x with PBS and
samples were stored at 40C for subsequent imaging. Samples were photographed by
bright-field and phase contrast microscopy.
In this work, 2nm GNPs surface functionalised with a 50:50 ratio of a thiolated α-Galactose derivative and a thiol PEG amine were examined for their toxicity towards normal (HaCaT) and
cancerous (HSC-3) human skin cell lines in vitro.
→ Using this simple ligand structure, GNPs are toxic to HSC-3 cells without affecting the normal cell line (HaCaT).
A notable cancer cell only selective toxicity occurs that depends upon the synthesis duration of the GNP, probably due to differences in ligand density.
Future Directions: Batch standardisation for the optimum synthesis time. Elucidation of the mechanisms of selective uptake & toxicity in various cancer and normal cell lines.
3.    Comparison of GNP amount/cell for different cell types by ICPMS
4.    Mechanisms of cell death.
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Fig. 1: Representation of the chemical structure of positively
charged carbohydrate-coated nanoparticles.
Methodology
Fig. 2: General reaction scheme for the synthesis of GNPs.
Preliminary Data
A. Effects between the same 50:50 GNP synthesized 
for different times (1h, 2h, 5h, overnight*).
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Conclusions / Future Directions
Fig. 3: Cell survival assessed by clonogenic assay for
GNP toxicity. Number of cell colonies (as % of no-drug
control) counted six days after acute (3hr) exposure to
various concentrations of GNPs, made with the same
ligand mixture but with different synthesis durations
(1hr, 2hr, 5hr and overnight). Cell types tested were
skin cancer (HSC3) and normal skin (HaCaT) cells lines.
B. GNPs accumulate in endosomes/lysosomes.
Fig.4: Localization of 50:50 2h synthesis GNPs in skin cancer (HSC3)
and normal (HaCaT) cells after acute (3h) exposure at 10 μg/ml.
EM data show large differences in uptake between HSC and HaCaT.
C. Does toxicity correlate with uptake?
HSC cells HaCaT cells
D. Changes in surface charge don’t fully explain
changes in toxicity between different NPs
Fig.5: Uptake data on GNPs synthesis times (1h, 2h, 5h and
overnight) in HSC cells. Silver staining appears stronger as the
synthesis time increases.
a. b.
c.Fig. 6: Clonogenic assay
of different charged
GNPs.
a. GNP 50:50 α-gal:AL, 
4nm, +ve charge
b. GNP α-gal, 4nm, 
neutral charge
c. PAMAM G4 dendrimer, 
4nm, +ve charge
In detail :
1. Explain differences between selective effect observed in cancer ≠ normal cell lines
2.    GNPs visualization for uptake assays and unravelling of internalization route
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* Overnight synthesis: resulted in bigger NPs =185 nm.
